Skip to main content

Table 9 Significant correlations among circulating/plasma inflammatory cytokines and miRNAs in the diabetic dyslipidemia context

From: Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

T2D-DLP group

 

IFNγ

TNFα

IL-1β

IL-6

Plasma miRNAs ↓

n

17

17

17

17

Plasma miR-21

r

0.251

0.941

− 0.884

− 0.352

P

0.682

0.013

0.052

0.563

Plasma miR-34a

r

− 0.111

0.962

− 0.580

− 0.711

P

0.854

0.010

0.302

0.174

Plasma miR-132

r

0.252

0.781

− 0.311

− 0.332

P

0.680

0.122

0.612

0.584

Plasma miR-143

r

0.091

− 0.200

0.283

− 0.412

P

0.880

0.751

0.651

0.480

Plasma miR-223

r

− 0.312

− 0.894

0.913

0.201

P

0.600

0.042

0.034

0.742

Plasma miR-122

r

0.033

− 0.280

0.623

− 0.504

P

0.962

0.643

0.262

0.383

Plasma miR-126

r

0.721

0.282

− 0.453

0.042

P

0.160

0.641

0.441

0.951

Plasma miR-155

r

− 0.421

− 0.784

0.892

0.152

P

0.421

0.124

0.040

0.801

Plasma miR-200b

r

0.252

− 0.572

0.412

0.822

P

0.671

0.314

0.491

0.083

Plasma miR-212

r

0.620

0.681

− 0.322

− 0.532

P

0.262

0.210

0.594

0.363

Plasma miR-218

r

0.100

0.452

− 0.462

− 0.564

P

0.871

0.441

0.431

0.322

  1. Spearman rank correlation test was used to assess relationships among variables. Bolded coefficients show a powerful correlation, and of them only italic underlined coefficients are significant (p < 0.05)